180 Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

180 Wealth Advisors’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.06M	Buy	152,829 +3,271	+2%	+$57.8K	0.31%	84
2026 Q1	$2.43M	Sell	149,558 -4,767	-3%	-$79.7K	0.28%	91
2025 Q4	$2.59M	Buy	154,325 +5,067	+3%	+$85.1K	0.29%	81
2025 Q3	$2.31M	Buy	149,258 +6,160	+4%	+$84.3K	0.28%	88
2025 Q2	$1.83M	Buy	143,098 +6,976	+5%	+$86K	0.26%	102
2025 Q1	$1.73M	Buy	136,122 +1,247	+0.9%	+$16.9K	0.28%	97
2024 Q4	$1.77M	Buy	134,875 +709	+0.5%	+$10.2K	0.28%	89
2024 Q3	$2.02M	Sell	134,166 -2,065	-2%	-$31.3K	0.32%	78
2024 Q2	$2.01M	Buy	136,231 +3,682	+3%	+$49.8K	0.33%	76
2024 Q1	$1.81M	Buy	132,549 +9,554	+8%	+$132K	0.32%	82
2023 Q4	$1.69M	Buy	122,995 +8,271	+7%	+$102K	0.34%	82
2023 Q3	$1.43M	Buy	114,724 +5,725	+5%	+$75.3K	0.32%	83
2023 Q2	$1.46M	Sell	108,999 -2,857	-3%	-$39.4K	0.32%	83
2023 Q1	$1.56M	Buy	111,856 +2,398	+2%	+$34.3K	0.36%	80
2022 Q4	$1.62M	Buy	109,458 +6,126	+6%	+$88.8K	0.38%	79
2022 Q3	$1.41M	Buy	103,332 +8,341	+9%	+$125K	0.39%	75
2022 Q2	$1.38M	Buy	94,991 +9,907	+12%	+$150K	0.35%	79
2022 Q1	$1.43M	Buy	85,084 +16,554	+24%	+$285K	0.31%	85
2021 Q4	$1.19M	Buy	68,530 +5,428	+9%	+$109K	0.27%	97
2021 Q3	$1.3M	Sell	63,102 -470	-0.7%	-$10.1K	0.29%	94
2021 Q2	$1.38M	Sell	63,572 -193	-0.3%	-$3.9K	0.32%	91
2021 Q1	$1.26M	Buy	63,765 +6,359	+11%	+$131K	0.31%	93
2020 Q4	$1.19M	Buy	57,406 +281	+0.5%	+$5.19K	0.34%	83
2020 Q3	$1.01M	Sell	57,125 -943	-2%	-$16.9K	0.38%	72
2020 Q2	$1.1M	Sell	58,068 -5,840	-9%	-$100K	0.44%	58
2020 Q1	$938K	Buy	63,908 +4,890	+8%	+$80.1K	0.49%	58
2019 Q4	$1.05M	Buy	59,018 +7,507	+15%	+$123K	0.42%	70
2019 Q3	$766K	Buy	51,511 +10,921	+27%	+$175K	0.34%	78
2019 Q2	$664K	Buy	40,590 +5,180	+15%	+$85.3K	0.3%	96
2019 Q1	$581K	Buy	+35,410	New	+$611K	0.26%	109

Other funds holding HQL

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

PFO

PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return

Decision Investments San Diego, California $110M AUM

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

SFS

Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

180 Wealth Advisors's HQL Position: Q2 2026 in Review

180 Wealth Advisors increased its abrdn Life Sciences Investors (HQL) stake by 2.2% in Q2 2026, buying an estimated $57.8K and bringing the position to 152,829 shares worth $3.06M. The position accounts for 0.31% of the portfolio, ranked #84.

180 Wealth Advisors first reported a position in HQL in Q1 2019 and has held it in 30 quarters since. 12 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

180 Wealth Advisors held 152,829 shares of abrdn Life Sciences Investors worth $3.06M as of Q2 2026.
180 Wealth Advisors bought 3,271 abrdn Life Sciences Investors shares in Q2 2026, an estimated $57.8K.
abrdn Life Sciences Investors made up 0.31% of 180 Wealth Advisors's portfolio in Q2 2026, its #84 holding.
180 Wealth Advisors first reported a position in abrdn Life Sciences Investors in Q1 2019 and has held it in 30 quarters since.
12 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.